Tilray Inc (NASDAQ: TLRY) has bolstered its executive team this morning, with the appointment of both a new chief operating officer, as well as a new chief financial officer. Both executives come with a long resume of high profile firms in which they have served senior roles.
Michael Kruteck will be taking over as CFO of the firm, which will be effective immediately after Tilray completes and files its Annual Report on Form 10-K for the fiscal year end. He will be replacing Mark Castaneda, who will be staying with the company in the role of Strategic Business Development following the customary transition of the CFO role.
Kruteck comes most recently from that of Pharmica Integrative Pharmacy where he served as CFO. Prior to this, he served in numerous senior financial roles at Molson Coors. Kruteck has specific experience in financial and operation transformation, supply chains and corporate finance.
Taking the role of COO will be that of Jon Levin. Levin joins the company from Revlon, where he served as General Manager of US Mass Markets for consumer products sold through retailers. He has over twenty five years experience in the fields of health and beauty and consumer packaged goods. Previously, he served at Ferrara Candy Company, Nautilus and Wrigley among others.
Tilray last traded at $17.37 on the Nasdaq.
Information for this briefing was found via Sedar and Tilray. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.